Discontinued — last reported Q3 '24
Business Segments · Operating Income (Loss)
Medical Devices — Operating Income (Loss)
Johnson & Johnson Medical Devices — Operating Income (Loss) decreased by 2.8% to $1.06B in Q3 2024 compared to the prior quarter. Year-over-year, this metric declined by 10.6%, from $1.19B to $1.06B. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2014
Last reportedQ3 2024
Rolls up toOperating Income
How to read this metric
Higher income indicates strong product demand, effective cost management, and operational leverage within the medical device market.
Detailed definition
This represents the core profitability of the medical technology segment after deducting operating expenses from segment...
Peer comparison
Standardized across the industry as 'Segment Operating Profit' or 'Segment EBIT' for diversified healthcare companies.
Metric ID:
jnj_segment_medtech_operating_income_lossHistorical Data
11 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.75B | $423.00M | $1.48B | $1.14B | $1.12B | $1.45B | $1.70B | $1.19B | $1.52B | $1.09B | $1.06B |
| QoQ Change | — | -75.8% | +249.2% | -22.7% | -1.5% | +28.6% | +17.6% | -30.3% | +28.3% | -28.4% | -2.8% |
| YoY Change | — | — | — | -34.7% | +165.7% | -2.2% | +48.9% | +5.4% | +5.2% | -35.9% | -10.6% |
Range$423.00M – $1.75B
CAGR-18.1%
Avg YoY Growth+17.7%
Median YoY Growth+1.5%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's medical devices — operating income (loss)?
- Johnson & Johnson (JNJ) reported medical devices — operating income (loss) of $1.06B in Q3 2024.
- How has Johnson & Johnson's medical devices — operating income (loss) changed year-over-year?
- Johnson & Johnson's medical devices — operating income (loss) decreased by 10.6% year-over-year, from $1.19B to $1.06B.
- What does medical devices — operating income (loss) mean?
- The profit or loss generated by the medical technology business segment from its core operations.